BioMed Research International

Tumor Cell Plasticity: From Tumorigenesis to Metastasis


Publishing date
01 Apr 2020
Status
Published
Submission deadline
29 Nov 2019

Lead Editor

1University of Medicine, Târgu Mureș, Romania

2National Institute of Oncology, Budapest, Hungary


Tumor Cell Plasticity: From Tumorigenesis to Metastasis

Description

One of the most challenging issues in oncology and pathology is that of tumor cell plasticity. This can be examined in vitro or in vivo and can be seen in humans, based on tumor tissues or circulating cells. Cell plasticity encompasses a large spectrum of issues, from pathogenesis of carcinogenesis through to tumor cells invasion and metastasis. Plasticity examination refers to epithelial-mesenchymal transition, mesenchymal-epithelial transition, endothelial-mesenchymal transition, trans- or dedifferentiation, proneural-mesenchymal transition, and any other aberrant behavior of tumor cells.

This special issue aims to collect papers which can be integrated into a common purpose: that of furthering the understanding of the plasticity of tumor cells at different stages of tumor progression. Review articles are welcomed, if they are based on immunohistochemical, molecular, or pathogenic mechanism of cancer cell plasticity.

Potential topics include but are not limited to the following:

  • Epithelial-mesenchymal/mesenchymal-epithelial/endothelial-mesenchymal transition within tumor cells and stroma
  • Proneural-mesenchymal transition within tumor cells and stroma
  • Tumor environment (stromal cells, inflammatory cells roles in tumor behavior)
  • New potential biomarkers involved in tumorigenesis and tumor invasion
  • Cell plasticity-based targeted therapy of cancer
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.